Cargando…
Correlation analysis of monocyte chemoattractant protein-1 and clinical characteristics and cognitive impairment in type 2 diabetes mellitus comorbid major depressive disorder
INTRODUCTION: Type 2 diabetes mellitus (T2DM) and major depressive disorder (MDD) are both chronic diseases, and they are often co-morbid. Usually, T2DM and MDD are associated with cognitive impairment, and the comorbidity status of both may increase the risk of cognitive impairment, but the underly...
Autores principales: | Cao, Fang, Yang, Mei, Cheng, Yuqi, Zhang, Xiuyue, Shi, Li, Li, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192629/ https://www.ncbi.nlm.nih.gov/pubmed/37213540 http://dx.doi.org/10.3389/fnagi.2023.1081393 |
Ejemplares similares
-
Somatic comorbidity and the progression of cognitive impairment
por: Bidzan, Leszek, et al.
Publicado: (2023) -
The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014) -
A Systematic Analysis on the Genes and Their Interaction Underlying the Comorbidity of Alzheimer's Disease and Major Depressive Disorder
por: Guo, Pan, et al.
Publicado: (2022) -
Gray matter reduction is associated with cognitive dysfunction in depressed patients comorbid with subclinical hypothyroidism
por: Zhao, Shuai, et al.
Publicado: (2023) -
Impact of impaired cerebral blood flow autoregulation on cognitive impairment
por: Wang, Shaoxun, et al.
Publicado: (2022)